 | |
John Paulson13F | |
| Paulson & Co. | |
| Last update 2024-02-16 | 17 Stocks (0 new) |
| Value $1.11 Bil | Turnover 15 % |
| Portfolio Report | |
John Paulson Profile
John Paulson is the President and Portfolio Manager of Paulson & Co. Inc. Paulson was ranked by Absolute Return Magazine as the 3rd largest hedge fund in the world managing approximately $29bn in merger, event and distressed strategies. Mr. Paulson received his Masters of Business Administration with high distinction, as a Baker Scholar, from Harvard Business School in 1980. He graduated summa cum laude in Finance from New York University's College of Business and Public Administration in 1978. Prior to forming Paulson in 1994, John was a general partner of Gruss Partners and a managing director in mergers and acquisitions at Bear Stearns.
John Paulson Investing Philosophy
John Paulson, a former mergers and acquisitions banker, established his firm as a merger arbitrage hedge fund manager, seeking to make money from situations when one public company announces plans to take over another. Merger arbitrage hedge funds primarily study equity markets, but they also research the market for credit default swaps, a form of insurance that starts paying out as soon as a credit security falls in value.
John Paulson's Portfolio
John Paulson Current Holdings
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
NMRK | Newmark Group Inc | 3,000,000 | 32,880.00 | +133.53% | 2.97 | +1.70% | 1.74 | +0.60% | -11.80% | 1,664.54 | Real Estate | |
MDGL | Madrigal Pharmaceuticals Inc | 1,105,741 | 255,846.35 | +121.15% | 23.09 | +12.65% | 5.60 | -0.82% | -3.94% | 4,668.06 | Biotechnology | |
NG | Novagold Resources Inc | 23,541,483 | 88,045.15 | +5.92% | 7.95 | +0.44% | 7.04 | -12.78% | -17.91% | 1,029.36 | Metals & Mining | |
BHC | Bausch Health Companies Inc | 26,439,035 | 212,041.06 | 0% | 19.14 | 0% | 7.24 | +4.12% | +7.23% | 3,152.11 | Drug Manufacturers | |
BSIG | BrightSphere Investment Group Inc | 8,950,121 | 171,484.32 | 0% | 15.48 | 0% | 21.56 | +15.28% | +18.53% | 867.32 | Asset Management | |
PPTA | Perpetua Resources Corp | 24,771,542 | 78,525.79 | 0% | 7.09 | 0% | 39.15 | +106.73% | +93.69% | 395.27 | Metals & Mining | |
AU | Anglogold Ashanti PLC | 3,833,492 | 71,647.97 | 0% | 6.47 | 0% | 0.91 | +46.68% | +27.92% | 9,951.80 | Metals & Mining | |
AEM | Agnico Eagle Mines Ltd | 783,561 | 42,978.32 | 0% | 3.88 | 0% | 0.16 | +30.22% | +16.69% | 31,615.32 | Metals & Mining | |
THRY | Thryv Holdings Inc | 2,000,000 | 40,700.00 | 0% | 3.67 | 0% | 5.69 | +19.57% | +7.17% | 775.52 | Interactive Media | |
THM | International Tower Hill Mines Ltd | 61,930,724 | 36,229.47 | 0% | 3.27 | 0% | 31.01 | +24.06% | +14.52% | 134.84 | Metals & Mining | |
SA | Seabridge Gold Inc | 2,070,000 | 25,109.10 | 0% | 2.27 | 0% | 2.46 | +42.05% | +24.48% | 1,311.49 | Metals & Mining | |
SSRM | SSR Mining Inc | 2,000,000 | 21,520.00 | 0% | 1.94 | 0% | 0.98 | -48.29% | -52.28% | 1,037.37 | Metals & Mining | |
EQX | Equinox Gold Corp | 2,500,000 | 12,225.00 | 0% | 1.10 | 0% | 0.80 | +31.10% | +19.84% | 1,938.84 | Metals & Mining | |
TMQ | Trilogy Metals Inc | 14,326,996 | 6,160.61 | 0% | 0.56 | 0% | 8.97 | -17.90% | -13.28% | 59.31 | Metals & Mining | |
IAG | Iamgold Corp | 1,850,000 | 4,680.50 | 0% | 0.42 | 0% | 0.38 | +55.56% | +43.87% | 1,810.14 | Metals & Mining | |
TELL | Tellurian Inc | 5,340,663 | 4,035.41 | 0% | 0.36 | 0% | 0.76 | -29.33% | -48.82% | 302.55 | Oil & Gas | |
BABA | Alibaba Group Holding Ltd | 50,000 | 3,875.50 | 0% | 0.35 | 0% | 0 | +1.22% | -11.13% | 167,628.43 | Retail - Cyclical | |
HZNP | Horizon Therapeutics PLC | 0 | 0 | Sold Out | 0 | -21.77% | 0 | +13.24% | +2.20% | 26,632.07 | Drug Manufacturers |
Total 18
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers